Table 2.
Adverse events associated with intralymphatic injections
| Active ILIT (61 injections) | Placebo ILIT (45 injections) | |||
|---|---|---|---|---|
| Early Reactions | Late Reactions | Early Reactions | Late Reactions | |
| Local Lymph Node Swelling | Mild: 6 | Mild: 14 | Mild: 1 | Mild: 1 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate: 0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |
| Local Itch | Mild: 6 | Mild: 11 | Mild: 2 | Mild: 1 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate: 0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |
| Local Redness | Mild: 11 | Mild: 21 | Mild: 0 | Mild: 0 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate: 0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |
| Nasal Symptoms | Mild: 1 | Mild: 1 | Mild: 4 | Mild: 4 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate:0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |
| Pulmonary Symptoms | Mild: 0 | Mild: 0 | Mild: 0 | Mild: 0 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate: 0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |
| Urticaria and angiooedema | Mild: 1 | Mild: 4 | Mild: 0 | Mild: 1 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate: 0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |
| Abdominal Symptoms | Mild: 0 | Mild: 1 | Mild: 0 | Mild: 1 |
| Moderate: 0 | Moderate: 0 | Moderate: 0 | Moderate: 0 | |
| Severe: 0 | Severe: 0 | Severe: 0 | Severe: 0 | |